Associate Professor, Medicine - Blood and Marrow Transplantation, Stanford University Medical Center
Hematology
Dr. Judith A. Shizuru, MD
|
|
Give Review
Judith Shizuru practices Hematology. She studied medicine at Stanford University School of Medicine. Stanford University School of Medicine is a one of the best medicals schools. Stanford University School of Medicine has a rank of 2 in research and a 25 in primary care She received awards:"CMS Meaningful Use Stage 1 Certification". Dr. Judith A. Shizuru is a published physician. She has 53 publications published. The most current publication "Treatment of 4T1 Metastatic Breast Cancer with Combined Hypofractionated Irradiation and Autologous T-Cell Infusion." She accepts Medicare payments and is listed with Medicare.gov.
Publications
- Treatment of 4T1 Metastatic Breast Cancer with Combined Hypofractionated Irradiation and Autologous T-Cell Infusion.
- Total lymphoid irradiation-antithymocyte globulin conditioning and allogeneic transplantation for patients with myelodysplastic syndromes and myeloproliferative neopla...
- Donor hematopoiesis in mice following total lymphoid irradiation requires host T regulatory cells for durable engraftment.
- B6.g7 mice reconstituted with BDC2·5 non-obese diabetic (BDC2·5NOD) stem cells do not develop autoimmune diabetes.
- Fine mapping of the Bmgr5 quantitative trait locus for allogeneic bone marrow engraftment in mice.
- Pathways analysis of differential gene expression induced by engrafting doses of total body irradiation for allogeneic bone marrow transplantation in mice.
- Host-derived CD4+ T cells attenuate stem cell-mediated transfer of autoimmune arthritis in lethally irradiated C57BL/6.g7 mice.
- Induced immune tolerance for kidney transplantation.
- A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies.
- Long-Term Outcome of Patients with Metastatic Breast Cancer Treated with High-Dose Chemotherapy and Transplantation of Purified Autologous Hematopoietic Stem Cells.
- Adoptive immunotherapy with cytokine-induced killer cells for patients with relapsed hematologic malignancies after allogeneic hematopoietic cell transplantation.
- Rapid reconstitution of antibody responses following transplantation of purified allogeneic hematopoietic stem cells.
- Allogeneic T cells impair engraftment and hematopoiesis after stem cell transplantation.
- Phase I/II trial of GN-BVC, a gemcitabine and vinorelbine-containing conditioning regimen for autologous hematopoietic cell transplantation in recurrent and refractory...
- Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.
- The biology of allogeneic hematopoietic cell resistance.
- Ineffective vaccination against solid tumors can be enhanced by hematopoietic cell transplantation.
- Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts.
- TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and un...
- A chromosome 16 quantitative trait locus regulates allogeneic bone marrow engraftment in nonmyeloablated mice.
- Identification of a major susceptibility locus for lethal graft-versus-host disease in MHC-matched mice.
- Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting.
- Purified hematopoietic stem cell allografts reconstitute immunity superior to bone marrow.
- The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmu...
- Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
- Tolerance and chimerism after renal and hematopoietic-cell transplantation.
- Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloab...
- Nonmyeloablative unrelated donor hematopoietic cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myeloma.
- Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell tran...
- Nonobese diabetic mice express aspects of both type 1 and type 2 diabetes.
- High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma.
- Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of po...
- Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors.
- Protective conditioning for acute graft-versus-host disease.
- Prevention of type 1 diabetes with major histocompatibility complex-compatible and nonmarrow ablative hematopoietic stem cell transplants.
- HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid leukemia.
- Engraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic cell transplantation is affected by CD8+ T-cell dose.
- Cytokines and cytotoxic pathways in engraftment resistance to purified allogeneic hematopoietic stem cells.
- Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease.
- Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid system.
- Approaches to transplantation tolerance in humans.
- Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma.
- Variable hematopoietic graft rejection and graft-versus-host disease in MHC-matched strains of mice.
- Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation.
- Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation.
- Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgraf...
- Purified allogeneic hematopoietic stem cell transplantation blocks diabetes pathogenesis in NOD mice.
- Biology of hematopoietic stem cells and progenitors: implications for clinical application.
- Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation.
- Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients.
- Non-myeloablative transplantation.
- European LeukemiaNet classification intermediate risk-1 cohort is associated with poor outcomes in adults with acute myeloid leukemia undergoing allogeneic hematopoiet...
Schools
Stanford University
University Ca Sf School Of Med
Doctors Specialties
- Internal Medicine
- Hematology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Stanford University -
UCSF -
Stanford University School of Medicine
Hospital
-
Stanford Health Care
Drug Facts
| NPI NUMBER | 1003942251 | |
| NPPES Provider LastName | SHIZURU | |
| NPPES Provider FirstName | JUDITH | |
| NPPES Provider ZIPCode | 943052200 | |
| NPPES Provider State | CA | |
| Specialty Description | Hematology | |
| Total Claim Count | 80.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1003942251 |
| Last Name Of The Provider | SHIZURU |
| First Name Of The Provider | JUDITH |
| View All |
Similar Doctors
|
|
Dr. Edwin Colloff, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eva Mortensen, MD |
|
|
Dr. Irine Vodkin, MD |
|
|
Dr. Aarti K. Rao, MD |
|
|
Dr. Gregory P. Naughton, MD |
|
|
Dr. David B. Miklos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert Lowsky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael J. Cascio, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donna M. Zulman, MD
This Doctor is OpenDoctor Recommended.
|